Skip to main content

Photoresponsive multifunctional DNA block copolymer nanocarriers for drug delivery and vaccine development

Article Category

Article available in the folowing languages:

DNA for drug delivery

A European study developed a drug delivery system based on DNA. This innovative design boasts controlled release and biocompatibility and is also envisioned in vaccine applications.


The development of effective drug delivery systems and vaccines remains a significant medical challenge. When designing such systems, scientists need to consider various aspects crucial for their performance such as composition, functionalisation, morphology and release mechanism. For in vivo applications, biodegradable block copolymers are a fundamental pre-requisite to yield harmless by-products easy to eliminate from the organism. However, the vast majority of delivery systems utilise spherical aggregates, which remain in circulation as they evade uptake by macrophages. To overcome this problem, scientists on the EU-funded PHOMULDNAPOL (Photoresponsive multifunctional DNA block copolymer nanocarriers for drug delivery and vaccine development) project proposed to develop nanocarriers based on DNA polymers. This system relies on complementary DNA sequences linked to specific molecules that produce multifunctional polymers when hybridised. Disassembly can be induced under specific conditions, providing controlled release. Polymers from polyethylene glycol and poly-ε-caprolactone were synthesised and assembled into worm-like micelles containing known anti-cancer drugs. The disassembly of these micelles was studied in vitro and their efficacy was tested in an in vivo cancer mouse model. Mice bearing tumours were injected with the formulation and exhibited a significant reduction in tumour size, clearly indicating that cancer treatment was effective. With respect to vaccines, nanoparticle-based systems deliver immune-stimulatory and co-stimulatory molecules to antigen presenting cells to trigger immune responses. The PHOMULDNAPOL consortium linked short single-stranded DNA molecules known as CpGs with polyanions to form micelles that contained the antigen for vaccination. The anti-tumour efficacy of this innovative vaccine was assessed in vivo with promising results. The use of DNA as a means of drug or vaccine delivery constitutes a novelty and is a significant advancement in the field given the versatility it offers.


DNA, drug delivery, vaccine, nanocarrier, polymer, polyethylene glycol, poly-ε-caprolactone, micelle, CpG polyanion

Discover other articles in the same domain of application